Plasma GABA predicts acute response to divalproex in mania

Biological Psychiatry

Volumn 39, Issue 4, 1996, Pages 278-284

  Petty, Frederick ^a,h   Rush, A John ^a   Davis, John M ^b   Calabrese, Joseph R ^c   Kimmel, Susan E ^c   Kramer, Gerald L ^a   Small, Joyce G ^d   Miller, Marvin J ^d   Swann, Alan E ^e   Orsulak, Paul J ^a   Blake, Molly E ^f   Bowden, Charles L ^g  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f ABBOTT LABORATORIES   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Bipolar disorder; Divalproex; GABA; Lithium; Mania; Response prediction; Valproic acid

Indexed keywords

4 AMINOBUTYRIC ACID; LITHIUM; PLACEBO; VALPROATE SEMISODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MANIA; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 9044227617     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00141-7     Document Type: Article

References (30)

1. Berrettini WH, Nurnberger JI, Hare T, Gershon ES, Post RM (1982): Plasma and CSF GABA in affective illness. Br J Psychiatry 141:483-487.
2. Berrettini WH, Nurnberger JI, Hare TA, Simmons-Alling S, Gershon ES, Post RM (1983): Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol Psychiatry 18:185-195.
3. Berrettini WH, Nurnberger JI, Hare TA, Simmons-Alling S, Gershon ES (1986): CSF GABA in euthymic manic-depressive patients and controls. Biol Psychiatry 21:842-844.
4. Biggs CS, Pearce BR, Fowler LJ, Whitton PS (1992): The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus - an in vivo microdialysis study. Brain Res 594:138-142.
5. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garzatrevino ES, Risch SC et al (1994): Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 271:918-924.
6. Calabrese JR, Delucchi GA (1990): Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 147:431-434.
7. Concas A, Mascia MP, Sanna E, Santoro G, Sana M, Biggio G (1991): In vivo administration of valproate decreases t-[S]butylbicyclophosphorthionate binding in rat brain. Naunyn-Schmied Arch Pharmacol 343:296-300.
8. Devanand D, Shapira B, Petty F, Kramer G, Fitzsimons L, Lerer B, Sackeim HA (1995): Effects of electroconvulsive therapy on plasma GABA. Convulsive Ther, In press.
9. Emrich HM, Zerssen DV, Kissling W, Moller H-J, Windorfer A (1980): Effect of sodium valproate on mania. Arch Psychiatr Nervenkr 229:1-16.
10. Loscher W (1989): Valproate enhances GABA turnover in the substantia nigra. Brain Res 501:198-203.
11. Loscher W (1993): Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 18:485-502.
12. Loscher W, Horstermann D (1994): Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma. Naunyn-Schmied Arch Pharmacol 349: 270-278.
13. Loscher W, Schmidt D (1980): Increase of human plasma GABA by sodium valproate. Epilepsia 21(6):611-615.
14. Loscher W, Schmidt D (1981): Plasma GABA levels in neurological patients under treatment with valproic acid. Life Sci 28:2383-2388.
15. Loscher W, Siemes H (1985): Cerebrospinal fluid gamma-aminobutyric acid levels in children with different types of epilepsy: Effect of anticonvulsant treatment. Epilepsia 26: 314-319.
16. Loscher W, Vetter M (1985): In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Biochem Pharmacol 34:1747-1756.
17. Manyam NVB, Hare TA (1980): Rapid and sensitive ion-exchange fluorometric measurement of gamma-aminobutyric acid in physiological fluids. Anal Biochem 101:349-355.
18. McElroy SL, Keck PE, Pope HG, Hudson JI (1992): Valproate in the treatment of bipolar disorder: Literature review and clinical guidelines. J Clin Psychopharmacol 12:42S-52S.
19. Motohashi N (1992): GABA receptor alterations after chronic lithium administration - comparison with carbamazepine and sodium valproate. Prog Neuro-Psych Biol Psych 16:571-579.
20. Petty F, Kramer G, Feldman M (1987): Is plasma GABA of peripheral origin? Biol Psychiatry 22:725-735.
21. Petty F, Kramer G (1992a): Stability of plasma GABA gamma-Aminobutyric acid with time in healthy controls. Biol Psychiatry 31:743-745.
22. Petty F, Kramer GL, Gullion CM, Rush AJ (1992b): Low plasma GABA in male patients with depression. Biol Psychiatry 32:354-363.
23. Petty F, Kramer GL, Fulton M, Moeller FG, Rush AJ (1993a): Low plasma GABA is a trait-like marker for bipolar illness. Neuropsychopharmacology 9:125-132.
24. Petty F, Steinberg J, Kramer GL, Fulton M, Moeller FG (1993b): Desipramine does not alter plasma GABA in patients with major depression. J Affective Dis 29:53-56.
25. Petty F (1994): Plasma GABA and mood disorders: A blood test for manic depressive disease? Clin Chem 40:296-302.
26. Pope HG Jr, McElroy SL, Keck PE, Hudson JI (1991): Valproate treatment in acute mania, a placebo-controlled study. Arch Gen Psychiatry 48:62-68.
27. Roy-Byrne PP, Cowley DS, Hommer D, Greenblatt DJ, Kramer GL, Petty F (1992): Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls. Psychopharmacology 109:153-156.
28. Spitzer RL, Endicott J, Robbins E (1975): Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 2nd ed. New York, NY: New York Psychiatric Institute.
29. Wolf R, Tscherne U (1994): Valproate effect on gamma-aminobutyric acid release in pars reticulata of substantia nigra - combination of push-pull perfusion and fluorescence histochemistry. Epilepsia 35:226-233.
30. Wolkowitz OM, Harris D, Turetsky NG, Reus VI, Johnson R, Gustafson M, Espinoza S, Petty F, Cooper TB, Sheline Y, Hargreaves WA: Alprazolam-neuroleptic treatment of schizophrenia. American Psychiatric Association Annual Meeting, San Francisco, CA, May 24-27, 1993.